Annals of oncology : official journal of the European Society for Medical Oncology r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA instname ETOP/IFCT 4-12 STIMULI Collaborators 2022, ' Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy – results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial ', Annals of Oncology, vol. 33, no. 1, pp. 67-79 . https://doi.org/10.1016/j.annonc.2021.09.011 Annals of Oncology, 33(1), 67-79. Oxford University Press
Journal of Thoracic Oncology, 13(10). International Association for the Study of Lung Cancer Van Veggel, B, Van Der Wekken, A, Hashemi, S, Cornelissen, R, Monkhorst, K, Heideman, D, Radonic, T, Schuuring, E, Smit, E & De Langen, J 2018, ' P2.13-42 Osimertinib Treatment for Patients with EGFR exon 20 Insertion Positive Non-Small-Cell Lung Cancer ', Journal of Thoracic Oncology, vol. 13, no. 10, pp. S815 . https://doi.org/10.1016/j.jtho.2018.08.1437
Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii524-viii525. Oxford University Press van Veggel, B, van der Wekken, A, Hashemi, S, Cornelissen, R, Monkhorst, K, Heideman, D, Radonic, T, Smit, E F, Schuuring, E & De Langen, J 2018, ' Osimertinib treatment for patients with EGFR exon 20 insertion positive non-small cell lung cancer ', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii524-viii525 . https://doi.org/10.1093/annonc/mdy292.072 Annals of Oncology, 29(Suppl.8), viii524-viii525. Oxford University Press
Niemeijer, A-L, Smit, E, Bahce, I, Hoekstra, O, Huisman, M, van Dongen, G A, Windhorst, B, Hendrikse, N, Poot, A J, Vugts, D, Leung, D K, Hayes, W, Smith, R A, Wilson, L M, Thunnissen, E & de langen, J 2017, ' Whole body PD-1 and PD-L1 PET in pts with NSCLC ', Annals of Oncology, vol. 28 . Annals of Oncology, 28. Oxford University Press